Published in Front Neurol on March 21, 2016
Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) Levels. Front Neurol (2016) 0.75
Juvenile Stroke. Dtsch Arztebl Int (2017) 0.75
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia (2013) 26.50
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA (1995) 11.45
Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med (2012) 8.19
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Homocysteine and atherothrombosis. N Engl J Med (1998) 6.70
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Prevalence of patent foramen ovale in patients with stroke. N Engl J Med (1988) 5.94
Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson (2008) 5.65
Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med (2007) 5.65
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69
Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med (2013) 4.62
Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke (2009) 4.14
Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol (2009) 4.11
The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology (1957) 3.98
Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol (2014) 3.96
Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology (2000) 3.64
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet (2001) 3.45
Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke (2009) 3.39
Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood (2007) 3.32
Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med (2010) 3.06
Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2004) 2.93
Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation (2010) 2.88
Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ (2004) 2.86
Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation (2014) 2.83
Cancer-associated thrombosis. N Engl J Med (2003) 2.76
Patent foramen ovale in young stroke patients. Lancet (1988) 2.68
The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol (2009) 2.59
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke (2015) 2.52
Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) (2002) 2.51
Antiphospholipid syndrome. Lancet (2010) 2.47
Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke (2001) 2.45
Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology (2010) 2.45
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39
Patent foramen ovale and stroke. Circulation (2005) 2.34
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol (2000) 2.16
Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol (2010) 2.11
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02
Microangiopathy of the brain and retina. Neurology (1979) 2.01
N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke (2014) 1.98
The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia (2002) 1.96
Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol (1998) 1.90
Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke (2009) 1.88
Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke (1989) 1.84
Hematologic disorders and ischemic stroke. A selective review. Stroke (1990) 1.84
Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol (2002) 1.82
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med (1992) 1.80
Cerebrovascular complications of Fabry's disease. Ann Neurol (1996) 1.78
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Structure, evolution, and biology of the MUC4 mucin. FASEB J (2007) 1.75
Pathophysiology of migraine. Annu Rev Physiol (2012) 1.73
Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke (2000) 1.71
Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol (2015) 1.70
Chickenpox and stroke in childhood: a study of frequency and causation. Stroke (2001) 1.69
Relation between migraine and stroke. Lancet Neurol (2005) 1.63
New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis (2009) 1.63
Detection and characterization of intracardiac thrombi on MR imaging. AJR Am J Roentgenol (2002) 1.61
Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation (2001) 1.60
Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry (2005) 1.58
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke (2009) 1.58
Planning genetic studies in human stroke: sample size estimates based on family history data. Neurology (2002) 1.58
Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging (2012) 1.56
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia (2010) 1.56
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood (2000) 1.53
A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder. FASEB J (2005) 1.53
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging. Cerebrovasc Dis (2009) 1.48
Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke (2013) 1.47
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation (2001) 1.46
The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain (2008) 1.45
Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42
Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain (1993) 1.42
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol (2008) 1.41
[Role of homocysteine in the acute phase of stroke]. Neurologia (2004) 1.40
Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med (1997) 1.36
Dissections of brain-supplying arteries. Nat Clin Pract Neurol (2008) 1.35
Giant thrombus trapped in foramen ovale with pulmonary embolus and stroke. J Am Soc Echocardiogr (2004) 1.33
Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol (2009) 1.32
Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat (1994) 1.29
The ocular manifestations in Fabry's disease. Arch Ophthalmol (1979) 1.25
Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke (1995) 1.24